Please note: This website includes an accessibility system. Press Control-F11 to adjust the website to the visually impaired who are using a screen reader; Press Control-F10 to open an accessibility menu.

by

Homepage
Tags search
Gilead Sciences

CTech 24/7

More stories in CTech

Gilead Sciences

5 stories about Gilead Sciences

Investments are flowing into synthetic biology - the red-hot field that will change the world
28.07.21|Sophie ShulmanSynthetic biology seemed like science fiction until the arrival of the coronavirus vaccines. But now the money has begun to flow and companies are revealing remarkable inventions: from bacteria that will attack tumors to shoes made of cobwebs
ForeBio is on its way to Nasdaq at a $500 million valuation
01.03.21|Tzally GreenbergThe company aims to raise $100 million in an April IPO, while Pontifax and OrbiMed who previously invested $21 million for a 12.5% stake in ForeBio’s shares are expected to make a $120 million profit
Gilead Builds on Kite Pharma Acquisition, Buys Second CAR-T Therapy Company
10.12.17|Lilach BaumerCalifornia-based Cell Design Labs will be acquired in a deal valued at up to $567 million
Kite Pharma’s Cancer Drug Gets Regulatory Nod
19.10.17|Lilach BaumerThe cancer-treatment company, bought by Gilead Science in August for $11.9 billion, will sell one treatment course of the drug for $373,000
Kite Pharma Sale Triggers Scientist Quarrel
02.10.17|Zohar Shahar LevyZelig Eshhar who patented the company’s core technology is now being sued by his former PhD student and current pharma entrepreneur

About CTech Terms of Use Privacy Policy

Back to Top